カテゴリー： Market Monitor Global, 世界, 医療/バイオ

薬物送達用リポソームの世界市場見通し2023年-2029年

◆英語タイトル：Liposomes for Drug Delivery Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY7689 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：112 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Liposomes for Drug Delivery Market 調査レポートは次の情報を含め、グローバルにおけるの薬物送達用リポソーム市場規模と予測を収録しています。・世界の薬物送達用リポソーム市場：売上、2018年-2023年、2024年-2029年
・世界の薬物送達用リポソーム市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の薬物送達用リポソーム市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「リポソームビタミン」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

薬物送達用リポソームのグローバル主要企業は、Lipoid Kosmetik、 Lucas Meyer Cosmetics、 Nippon Fine Chemical、 Enoc Solutions、 Nanovec、 Lipotec、 Croda、 H&A Pharmachem、 Lipomize、 ID bio、 BioSpectrum、 Derma Clinical、 Kewpie Corporation、 Nanohealth Biotech、 Creative Biostructure、 Phenbiox、 NOF CORPORATION、 KYOWA PHARMA CHEMICAL、 Nikko Chemicalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、薬物送達用リポソームのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の薬物送達用リポソーム市場：タイプ別、2018年-2023年、2024年-2029年
世界の薬物送達用リポソーム市場：タイプ別市場シェア、2022年
・リポソームビタミン、リポソームセラミド、リポソームCoQ10、その他

世界の薬物送達用リポソーム市場：用途別、2018年-2023年、2024年-2029年
世界の薬物送達用リポソーム市場：用途別市場シェア、2022年
・親水性治療薬、疎水性治療薬

世界の薬物送達用リポソーム市場：地域・国別、2018年-2023年、2024年-2029年
世界の薬物送達用リポソーム市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における薬物送達用リポソームのグローバル売上、2018年-2023年
・主要企業における薬物送達用リポソームのグローバル売上シェア、2022年
・主要企業における薬物送達用リポソームのグローバル販売量、2018年-2023年
・主要企業における薬物送達用リポソームのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Lipoid Kosmetik、 Lucas Meyer Cosmetics、 Nippon Fine Chemical、 Enoc Solutions、 Nanovec、 Lipotec、 Croda、 H&A Pharmachem、 Lipomize、 ID bio、 BioSpectrum、 Derma Clinical、 Kewpie Corporation、 Nanohealth Biotech、 Creative Biostructure、 Phenbiox、 NOF CORPORATION、 KYOWA PHARMA CHEMICAL、 Nikko Chemicals

*************************************************************

・調査・分析レポートの概要
薬物送達用リポソーム市場の定義
市場セグメント
世界の薬物送達用リポソーム市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の薬物送達用リポソーム市場規模
世界の薬物送達用リポソーム市場規模：2022年 VS 2029年
世界の薬物送達用リポソーム市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの薬物送達用リポソームの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の薬物送達用リポソーム製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：リポソームビタミン、リポソームセラミド、リポソームCoQ10、その他
薬物送達用リポソームのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：親水性治療薬、疎水性治療薬
薬物送達用リポソームの用途別グローバル売上・予測

・地域別市場分析
地域別薬物送達用リポソーム市場規模 2022年と2029年
地域別薬物送達用リポソーム売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Lipoid Kosmetik、 Lucas Meyer Cosmetics、 Nippon Fine Chemical、 Enoc Solutions、 Nanovec、 Lipotec、 Croda、 H&A Pharmachem、 Lipomize、 ID bio、 BioSpectrum、 Derma Clinical、 Kewpie Corporation、 Nanohealth Biotech、 Creative Biostructure、 Phenbiox、 NOF CORPORATION、 KYOWA PHARMA CHEMICAL、 Nikko Chemicals
...

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
This report aims to provide a comprehensive presentation of the global market for Liposomes for Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomes for Drug Delivery. This report contains market size and forecasts of Liposomes for Drug Delivery in global, including the following market information:
Global Liposomes for Drug Delivery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Liposomes for Drug Delivery Market Sales, 2018-2023, 2024-2029, (Tons)
Global top five Liposomes for Drug Delivery companies in 2022 (%)
The global Liposomes for Drug Delivery market was valued at US$ 3431.8 million in 2022 and is projected to reach US$ 4211.1 million by 2029, at a CAGR of 3.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America dominated the market with market share of 44% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12%.
Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma and Sigma-Tau Group are the top 6 players of Liposomes Drug Delivery, with about 77% market shares.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liposomes for Drug Delivery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liposomes for Drug Delivery Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Liposomes for Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Liposome Vitamin
Liposome Ceramide
Liposome CoQ10
Others
Global Liposomes for Drug Delivery Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Liposomes for Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Hydrophilic Drugs
Hydrophobic Drugs
Global Liposomes for Drug Delivery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Liposomes for Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liposomes for Drug Delivery revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Liposomes for Drug Delivery revenues share in global market, 2022 (%)
Key companies Liposomes for Drug Delivery sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Liposomes for Drug Delivery sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lipoid Kosmetik
Lucas Meyer Cosmetics
Nippon Fine Chemical
Enoc Solutions
Nanovec
Lipotec
Croda
H&A Pharmachem
Lipomize
ID bio
BioSpectrum
Derma Clinical
Kewpie Corporation
Nanohealth Biotech
Creative Biostructure
Phenbiox
NOF CORPORATION
KYOWA PHARMA CHEMICAL
Nikko Chemicals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Liposomes for Drug Delivery, market overview.
Chapter 2: Global Liposomes for Drug Delivery market size in revenue and volume.
Chapter 3: Detailed analysis of Liposomes for Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Liposomes for Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Liposomes for Drug Delivery capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Liposomes for Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liposomes for Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liposomes for Drug Delivery Overall Market Size
2.1 Global Liposomes for Drug Delivery Market Size: 2022 VS 2029
2.2 Global Liposomes for Drug Delivery Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Liposomes for Drug Delivery Sales: 2018-2029
3 Company Landscape
3.1 Top Liposomes for Drug Delivery Players in Global Market
3.2 Top Global Liposomes for Drug Delivery Companies Ranked by Revenue
3.3 Global Liposomes for Drug Delivery Revenue by Companies
3.4 Global Liposomes for Drug Delivery Sales by Companies
3.5 Global Liposomes for Drug Delivery Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Liposomes for Drug Delivery Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Liposomes for Drug Delivery Product Type
3.8 Tier 1, Tier 2 and Tier 3 Liposomes for Drug Delivery Players in Global Market
3.8.1 List of Global Tier 1 Liposomes for Drug Delivery Companies
3.8.2 List of Global Tier 2 and Tier 3 Liposomes for Drug Delivery Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Liposomes for Drug Delivery Market Size Markets, 2022 & 2029
4.1.2 Liposome Vitamin
4.1.3 Liposome Ceramide
4.1.4 Liposome CoQ10
4.1.5 Others
4.2 By Type – Global Liposomes for Drug Delivery Revenue & Forecasts
4.2.1 By Type – Global Liposomes for Drug Delivery Revenue, 2018-2023
4.2.2 By Type – Global Liposomes for Drug Delivery Revenue, 2024-2029
4.2.3 By Type – Global Liposomes for Drug Delivery Revenue Market Share, 2018-2029
4.3 By Type – Global Liposomes for Drug Delivery Sales & Forecasts
4.3.1 By Type – Global Liposomes for Drug Delivery Sales, 2018-2023
4.3.2 By Type – Global Liposomes for Drug Delivery Sales, 2024-2029
4.3.3 By Type – Global Liposomes for Drug Delivery Sales Market Share, 2018-2029
4.4 By Type – Global Liposomes for Drug Delivery Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Liposomes for Drug Delivery Market Size, 2022 & 2029
5.1.2 Hydrophilic Drugs
5.1.3 Hydrophobic Drugs
5.2 By Application – Global Liposomes for Drug Delivery Revenue & Forecasts
5.2.1 By Application – Global Liposomes for Drug Delivery Revenue, 2018-2023
5.2.2 By Application – Global Liposomes for Drug Delivery Revenue, 2024-2029
5.2.3 By Application – Global Liposomes for Drug Delivery Revenue Market Share, 2018-2029
5.3 By Application – Global Liposomes for Drug Delivery Sales & Forecasts
5.3.1 By Application – Global Liposomes for Drug Delivery Sales, 2018-2023
5.3.2 By Application – Global Liposomes for Drug Delivery Sales, 2024-2029
5.3.3 By Application – Global Liposomes for Drug Delivery Sales Market Share, 2018-2029
5.4 By Application – Global Liposomes for Drug Delivery Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Liposomes for Drug Delivery Market Size, 2022 & 2029
6.2 By Region – Global Liposomes for Drug Delivery Revenue & Forecasts
6.2.1 By Region – Global Liposomes for Drug Delivery Revenue, 2018-2023
6.2.2 By Region – Global Liposomes for Drug Delivery Revenue, 2024-2029
6.2.3 By Region – Global Liposomes for Drug Delivery Revenue Market Share, 2018-2029
6.3 By Region – Global Liposomes for Drug Delivery Sales & Forecasts
6.3.1 By Region – Global Liposomes for Drug Delivery Sales, 2018-2023
6.3.2 By Region – Global Liposomes for Drug Delivery Sales, 2024-2029
6.3.3 By Region – Global Liposomes for Drug Delivery Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Liposomes for Drug Delivery Revenue, 2018-2029
6.4.2 By Country – North America Liposomes for Drug Delivery Sales, 2018-2029
6.4.3 US Liposomes for Drug Delivery Market Size, 2018-2029
6.4.4 Canada Liposomes for Drug Delivery Market Size, 2018-2029
6.4.5 Mexico Liposomes for Drug Delivery Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Liposomes for Drug Delivery Revenue, 2018-2029
6.5.2 By Country – Europe Liposomes for Drug Delivery Sales, 2018-2029
6.5.3 Germany Liposomes for Drug Delivery Market Size, 2018-2029
6.5.4 France Liposomes for Drug Delivery Market Size, 2018-2029
6.5.5 U.K. Liposomes for Drug Delivery Market Size, 2018-2029
6.5.6 Italy Liposomes for Drug Delivery Market Size, 2018-2029
6.5.7 Russia Liposomes for Drug Delivery Market Size, 2018-2029
6.5.8 Nordic Countries Liposomes for Drug Delivery Market Size, 2018-2029
6.5.9 Benelux Liposomes for Drug Delivery Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Liposomes for Drug Delivery Revenue, 2018-2029
6.6.2 By Region – Asia Liposomes for Drug Delivery Sales, 2018-2029
6.6.3 China Liposomes for Drug Delivery Market Size, 2018-2029
6.6.4 Japan Liposomes for Drug Delivery Market Size, 2018-2029
6.6.5 South Korea Liposomes for Drug Delivery Market Size, 2018-2029
6.6.6 Southeast Asia Liposomes for Drug Delivery Market Size, 2018-2029
6.6.7 India Liposomes for Drug Delivery Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Liposomes for Drug Delivery Revenue, 2018-2029
6.7.2 By Country – South America Liposomes for Drug Delivery Sales, 2018-2029
6.7.3 Brazil Liposomes for Drug Delivery Market Size, 2018-2029
6.7.4 Argentina Liposomes for Drug Delivery Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Liposomes for Drug Delivery Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Liposomes for Drug Delivery Sales, 2018-2029
6.8.3 Turkey Liposomes for Drug Delivery Market Size, 2018-2029
6.8.4 Israel Liposomes for Drug Delivery Market Size, 2018-2029
6.8.5 Saudi Arabia Liposomes for Drug Delivery Market Size, 2018-2029
6.8.6 UAE Liposomes for Drug Delivery Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Lipoid Kosmetik
7.1.1 Lipoid Kosmetik Company Summary
7.1.2 Lipoid Kosmetik Business Overview
7.1.3 Lipoid Kosmetik Liposomes for Drug Delivery Major Product Offerings
7.1.4 Lipoid Kosmetik Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.1.5 Lipoid Kosmetik Key News & Latest Developments
7.2 Lucas Meyer Cosmetics
7.2.1 Lucas Meyer Cosmetics Company Summary
7.2.2 Lucas Meyer Cosmetics Business Overview
7.2.3 Lucas Meyer Cosmetics Liposomes for Drug Delivery Major Product Offerings
7.2.4 Lucas Meyer Cosmetics Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.2.5 Lucas Meyer Cosmetics Key News & Latest Developments
7.3 Nippon Fine Chemical
7.3.1 Nippon Fine Chemical Company Summary
7.3.2 Nippon Fine Chemical Business Overview
7.3.3 Nippon Fine Chemical Liposomes for Drug Delivery Major Product Offerings
7.3.4 Nippon Fine Chemical Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.3.5 Nippon Fine Chemical Key News & Latest Developments
7.4 Enoc Solutions
7.4.1 Enoc Solutions Company Summary
7.4.2 Enoc Solutions Business Overview
7.4.3 Enoc Solutions Liposomes for Drug Delivery Major Product Offerings
7.4.4 Enoc Solutions Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.4.5 Enoc Solutions Key News & Latest Developments
7.5 Nanovec
7.5.1 Nanovec Company Summary
7.5.2 Nanovec Business Overview
7.5.3 Nanovec Liposomes for Drug Delivery Major Product Offerings
7.5.4 Nanovec Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.5.5 Nanovec Key News & Latest Developments
7.6 Lipotec
7.6.1 Lipotec Company Summary
7.6.2 Lipotec Business Overview
7.6.3 Lipotec Liposomes for Drug Delivery Major Product Offerings
7.6.4 Lipotec Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.6.5 Lipotec Key News & Latest Developments
7.7 Croda
7.7.1 Croda Company Summary
7.7.2 Croda Business Overview
7.7.3 Croda Liposomes for Drug Delivery Major Product Offerings
7.7.4 Croda Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.7.5 Croda Key News & Latest Developments
7.8 H&A Pharmachem
7.8.1 H&A Pharmachem Company Summary
7.8.2 H&A Pharmachem Business Overview
7.8.3 H&A Pharmachem Liposomes for Drug Delivery Major Product Offerings
7.8.4 H&A Pharmachem Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.8.5 H&A Pharmachem Key News & Latest Developments
7.9 Lipomize
7.9.1 Lipomize Company Summary
7.9.2 Lipomize Business Overview
7.9.3 Lipomize Liposomes for Drug Delivery Major Product Offerings
7.9.4 Lipomize Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.9.5 Lipomize Key News & Latest Developments
7.10 ID bio
7.10.1 ID bio Company Summary
7.10.2 ID bio Business Overview
7.10.3 ID bio Liposomes for Drug Delivery Major Product Offerings
7.10.4 ID bio Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.10.5 ID bio Key News & Latest Developments
7.11 BioSpectrum
7.11.1 BioSpectrum Company Summary
7.11.2 BioSpectrum Liposomes for Drug Delivery Business Overview
7.11.3 BioSpectrum Liposomes for Drug Delivery Major Product Offerings
7.11.4 BioSpectrum Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.11.5 BioSpectrum Key News & Latest Developments
7.12 Derma Clinical
7.12.1 Derma Clinical Company Summary
7.12.2 Derma Clinical Liposomes for Drug Delivery Business Overview
7.12.3 Derma Clinical Liposomes for Drug Delivery Major Product Offerings
7.12.4 Derma Clinical Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.12.5 Derma Clinical Key News & Latest Developments
7.13 Kewpie Corporation
7.13.1 Kewpie Corporation Company Summary
7.13.2 Kewpie Corporation Liposomes for Drug Delivery Business Overview
7.13.3 Kewpie Corporation Liposomes for Drug Delivery Major Product Offerings
7.13.4 Kewpie Corporation Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.13.5 Kewpie Corporation Key News & Latest Developments
7.14 Nanohealth Biotech
7.14.1 Nanohealth Biotech Company Summary
7.14.2 Nanohealth Biotech Business Overview
7.14.3 Nanohealth Biotech Liposomes for Drug Delivery Major Product Offerings
7.14.4 Nanohealth Biotech Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.14.5 Nanohealth Biotech Key News & Latest Developments
7.15 Creative Biostructure
7.15.1 Creative Biostructure Company Summary
7.15.2 Creative Biostructure Business Overview
7.15.3 Creative Biostructure Liposomes for Drug Delivery Major Product Offerings
7.15.4 Creative Biostructure Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.15.5 Creative Biostructure Key News & Latest Developments
7.16 Phenbiox
7.16.1 Phenbiox Company Summary
7.16.2 Phenbiox Business Overview
7.16.3 Phenbiox Liposomes for Drug Delivery Major Product Offerings
7.16.4 Phenbiox Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.16.5 Phenbiox Key News & Latest Developments
7.17 NOF CORPORATION
7.17.1 NOF CORPORATION Company Summary
7.17.2 NOF CORPORATION Business Overview
7.17.3 NOF CORPORATION Liposomes for Drug Delivery Major Product Offerings
7.17.4 NOF CORPORATION Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.17.5 NOF CORPORATION Key News & Latest Developments
7.18 KYOWA PHARMA CHEMICAL
7.18.1 KYOWA PHARMA CHEMICAL Company Summary
7.18.2 KYOWA PHARMA CHEMICAL Business Overview
7.18.3 KYOWA PHARMA CHEMICAL Liposomes for Drug Delivery Major Product Offerings
7.18.4 KYOWA PHARMA CHEMICAL Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.18.5 KYOWA PHARMA CHEMICAL Key News & Latest Developments
7.19 Nikko Chemicals
7.19.1 Nikko Chemicals Company Summary
7.19.2 Nikko Chemicals Business Overview
7.19.3 Nikko Chemicals Liposomes for Drug Delivery Major Product Offerings
7.19.4 Nikko Chemicals Liposomes for Drug Delivery Sales and Revenue in Global (2018-2023)
7.19.5 Nikko Chemicals Key News & Latest Developments
8 Global Liposomes for Drug Delivery Production Capacity, Analysis
8.1 Global Liposomes for Drug Delivery Production Capacity, 2018-2029
8.2 Liposomes for Drug Delivery Production Capacity of Key Manufacturers in Global Market
8.3 Global Liposomes for Drug Delivery Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Liposomes for Drug Delivery Supply Chain Analysis
10.1 Liposomes for Drug Delivery Industry Value Chain
10.2 Liposomes for Drug Delivery Upstream Market
10.3 Liposomes for Drug Delivery Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Liposomes for Drug Delivery Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Liposomes for Drug Delivery in Global Market
Table 2. Top Liposomes for Drug Delivery Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Liposomes for Drug Delivery Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Liposomes for Drug Delivery Revenue Share by Companies, 2018-2023
Table 5. Global Liposomes for Drug Delivery Sales by Companies, (Tons), 2018-2023
Table 6. Global Liposomes for Drug Delivery Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Liposomes for Drug Delivery Price (2018-2023) & (US$/Kg)
Table 8. Global Manufacturers Liposomes for Drug Delivery Product Type
Table 9. List of Global Tier 1 Liposomes for Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liposomes for Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Liposomes for Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Liposomes for Drug Delivery Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Liposomes for Drug Delivery Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Liposomes for Drug Delivery Sales (Tons), 2018-2023
Table 15. By Type - Global Liposomes for Drug Delivery Sales (Tons), 2024-2029
Table 16. By Application – Global Liposomes for Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Liposomes for Drug Delivery Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Liposomes for Drug Delivery Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Liposomes for Drug Delivery Sales (Tons), 2018-2023
Table 20. By Application - Global Liposomes for Drug Delivery Sales (Tons), 2024-2029
Table 21. By Region – Global Liposomes for Drug Delivery Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Liposomes for Drug Delivery Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Liposomes for Drug Delivery Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Liposomes for Drug Delivery Sales (Tons), 2018-2023
Table 25. By Region - Global Liposomes for Drug Delivery Sales (Tons), 2024-2029
Table 26. By Country - North America Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Liposomes for Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Liposomes for Drug Delivery Sales, (Tons), 2018-2023
Table 29. By Country - North America Liposomes for Drug Delivery Sales, (Tons), 2024-2029
Table 30. By Country - Europe Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Liposomes for Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Liposomes for Drug Delivery Sales, (Tons), 2018-2023
Table 33. By Country - Europe Liposomes for Drug Delivery Sales, (Tons), 2024-2029
Table 34. By Region - Asia Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Liposomes for Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Liposomes for Drug Delivery Sales, (Tons), 2018-2023
Table 37. By Region - Asia Liposomes for Drug Delivery Sales, (Tons), 2024-2029
Table 38. By Country - South America Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Liposomes for Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Liposomes for Drug Delivery Sales, (Tons), 2018-2023
Table 41. By Country - South America Liposomes for Drug Delivery Sales, (Tons), 2024-2029
Table 42. By Country - Middle East & Africa Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Liposomes for Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Liposomes for Drug Delivery Sales, (Tons), 2018-2023
Table 45. By Country - Middle East & Africa Liposomes for Drug Delivery Sales, (Tons), 2024-2029
Table 46. Lipoid Kosmetik Company Summary
Table 47. Lipoid Kosmetik Liposomes for Drug Delivery Product Offerings
Table 48. Lipoid Kosmetik Liposomes for Drug Delivery Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 49. Lipoid Kosmetik Key News & Latest Developments
Table 50. Lucas Meyer Cosmetics Company Summary
Table 51. Lucas Meyer Cosmetics Liposomes for Drug Delivery Product Offerings
Table 52. Lucas Meyer Cosmetics Liposomes for Drug Delivery Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 53. Lucas Meyer Cosmetics Key News & Latest Developments
Table 54. Nippon Fine Chemical Company Summary
Table 55. Nippon Fine Chemical Liposomes for Drug Delivery Product Offerings
Table 56. Nippon Fine Chemical Liposomes for Drug Delivery Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 57. Nippon Fine Chemical Key News & Latest Developments
Table 58. Enoc Solutions Company Summary
Table 59. Enoc Solutions Liposomes for Drug Delivery Product Offerings
Table 60. Enoc Solutions Liposomes for Drug Delivery Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 61. Enoc Solutions Key News & Latest Developments
Table 62. Nanovec Company Summary
Table 63. Nanovec Liposomes for Drug Delivery Product Offerings
Table 64. Nanovec Liposomes for Drug Delivery Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 65. Nanovec Key News & Latest Developments
Table 66. Lipotec Company Summary
Table 67. Lipotec Liposomes for Drug Delivery Product Offerings
Table 68. Lipotec Liposomes for Drug Delivery Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 69. Lipotec Key News & Latest Developments
Table 70. Croda Company Summary
Table 71. Croda Liposomes for Drug Delivery Product Offerings
Table 72. Croda Liposomes for Drug Delivery Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 73. Croda Key News & Latest Developments
Table 74. H&A Pharmachem Company Summary
Table 75. H&A Pharmachem Liposomes for Drug Delivery Product Offerings
Table 76. H&A Pharmachem Liposomes for Drug Delivery Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 77. H&A Pharmachem Key News & Latest Developments
Table 78. Lipomize Company Summary
Table 79. Lipomize Liposomes for Drug Delivery Product Offerings
Table 80. Lipomize Liposomes for Drug Delivery Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 81. Lipomize Key News & Latest Developments
Table 82. ID bio Company Summary
Table 83. ID bio Liposomes for Drug Delivery Product Offerings
Table 84. ID bio Liposomes for Drug Delivery Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 85. ID bio Key News & Latest Developments
Table 86. BioSpectrum Company Summary
Table 87. BioSpectrum Liposomes for Drug Delivery Product Offerings
Table 88. BioSpectrum Liposomes for Drug Delivery Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 89. BioSpectrum Key News & Latest Developments
Table 90. Derma Clinical Company Summary
Table 91. Derma Clinical Liposomes for Drug Delivery Product Offerings
Table 92. Derma Clinical Liposomes for Drug Delivery Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 93. Derma Clinical Key News & Latest Developments
Table 94. Kewpie Corporation Company Summary
Table 95. Kewpie Corporation Liposomes for Drug Delivery Product Offerings
Table 96. Kewpie Corporation Liposomes for Drug Delivery Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 97. Kewpie Corporation Key News & Latest Developments
Table 98. Nanohealth Biotech Company Summary
Table 99. Nanohealth Biotech Liposomes for Drug Delivery Product Offerings
Table 100. Nanohealth Biotech Liposomes for Drug Delivery Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 101. Nanohealth Biotech Key News & Latest Developments
Table 102. Creative Biostructure Company Summary
Table 103. Creative Biostructure Liposomes for Drug Delivery Product Offerings
Table 104. Creative Biostructure Liposomes for Drug Delivery Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 105. Creative Biostructure Key News & Latest Developments
Table 106. Phenbiox Company Summary
Table 107. Phenbiox Liposomes for Drug Delivery Product Offerings
Table 108. Phenbiox Liposomes for Drug Delivery Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 109. Phenbiox Key News & Latest Developments
Table 110. NOF CORPORATION Company Summary
Table 111. NOF CORPORATION Liposomes for Drug Delivery Product Offerings
Table 112. NOF CORPORATION Liposomes for Drug Delivery Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 113. NOF CORPORATION Key News & Latest Developments
Table 114. KYOWA PHARMA CHEMICAL Company Summary
Table 115. KYOWA PHARMA CHEMICAL Liposomes for Drug Delivery Product Offerings
Table 116. KYOWA PHARMA CHEMICAL Liposomes for Drug Delivery Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 117. KYOWA PHARMA CHEMICAL Key News & Latest Developments
Table 118. Nikko Chemicals Company Summary
Table 119. Nikko Chemicals Liposomes for Drug Delivery Product Offerings
Table 120. Nikko Chemicals Liposomes for Drug Delivery Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 121. Nikko Chemicals Key News & Latest Developments
Table 122. Liposomes for Drug Delivery Production Capacity (Tons) of Key Manufacturers in Global Market, 2021-2023 (Tons)
Table 123. Global Liposomes for Drug Delivery Capacity Market Share of Key Manufacturers, 2021-2023
Table 124. Global Liposomes for Drug Delivery Production by Region, 2018-2023 (Tons)
Table 125. Global Liposomes for Drug Delivery Production by Region, 2024-2029 (Tons)
Table 126. Liposomes for Drug Delivery Market Opportunities & Trends in Global Market
Table 127. Liposomes for Drug Delivery Market Drivers in Global Market
Table 128. Liposomes for Drug Delivery Market Restraints in Global Market
Table 129. Liposomes for Drug Delivery Raw Materials
Table 130. Liposomes for Drug Delivery Raw Materials Suppliers in Global Market
Table 131. Typical Liposomes for Drug Delivery Downstream
Table 132. Liposomes for Drug Delivery Downstream Clients in Global Market
Table 133. Liposomes for Drug Delivery Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Liposomes for Drug Delivery Segment by Type in 2022
Figure 2. Liposomes for Drug Delivery Segment by Application in 2022
Figure 3. Global Liposomes for Drug Delivery Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Liposomes for Drug Delivery Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Liposomes for Drug Delivery Revenue, 2018-2029 (US$, Mn)
Figure 7. Liposomes for Drug Delivery Sales in Global Market: 2018-2029 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Liposomes for Drug Delivery Revenue in 2022
Figure 9. By Type - Global Liposomes for Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Liposomes for Drug Delivery Revenue Market Share, 2018-2029
Figure 11. By Type - Global Liposomes for Drug Delivery Sales Market Share, 2018-2029
Figure 12. By Type - Global Liposomes for Drug Delivery Price (US$/Kg), 2018-2029
Figure 13. By Application - Global Liposomes for Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Liposomes for Drug Delivery Revenue Market Share, 2018-2029
Figure 15. By Application - Global Liposomes for Drug Delivery Sales Market Share, 2018-2029
Figure 16. By Application - Global Liposomes for Drug Delivery Price (US$/Kg), 2018-2029
Figure 17. By Region - Global Liposomes for Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Liposomes for Drug Delivery Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Liposomes for Drug Delivery Revenue Market Share, 2018-2029
Figure 20. By Region - Global Liposomes for Drug Delivery Sales Market Share, 2018-2029
Figure 21. By Country - North America Liposomes for Drug Delivery Revenue Market Share, 2018-2029
Figure 22. By Country - North America Liposomes for Drug Delivery Sales Market Share, 2018-2029
Figure 23. US Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Liposomes for Drug Delivery Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Liposomes for Drug Delivery Sales Market Share, 2018-2029
Figure 28. Germany Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 29. France Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Liposomes for Drug Delivery Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Liposomes for Drug Delivery Sales Market Share, 2018-2029
Figure 37. China Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 41. India Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Liposomes for Drug Delivery Revenue Market Share, 2018-2029
Figure 43. By Country - South America Liposomes for Drug Delivery Sales Market Share, 2018-2029
Figure 44. Brazil Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Liposomes for Drug Delivery Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Liposomes for Drug Delivery Sales Market Share, 2018-2029
Figure 48. Turkey Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Liposomes for Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 52. Global Liposomes for Drug Delivery Production Capacity (Tons), 2018-2029
Figure 53. The Percentage of Production Liposomes for Drug Delivery by Region, 2022 VS 2029
Figure 54. Liposomes for Drug Delivery Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 薬物送達用リポソームの世界市場見通し2023年-2029年(Liposomes for Drug Delivery Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

薬物送達用リポソームの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp